From GPUs to AI and quantum: three waves of acceleration in bioinformatics

Area of Science:

• Bioinformatics and computational biology
• Life sciences data analysis
• High-performance computing

Background:

• The life sciences generate vast datasets, driving a transition from model-driven to data-driven research.
• Efficient data processing necessitates the use of massively parallel accelerators like graphics processing units (GPUs).
• Advancements in computational techniques, including artificial intelligence (AI) and quantum computing, are rapidly evolving.

Purpose of the Study:

• To identify and categorize the key waves of computational acceleration impacting bioinformatics.
• To examine the applications of these acceleration technologies within the life sciences.
• To provide insights into the future trajectory of computational methods in drug discovery and bioinformatics.

Main Methods:

• Review and analysis of current trends in high-performance computing for bioinformatics.
• Identification of three distinct "waves" of computational acceleration: GPU computing, AI, and quantum computing.
• Exploration of the specific applications and implications of each wave in life sciences research.

Main Results:

• The first wave involves widespread adoption of graphics processing units (GPUs) for parallel processing in bioinformatics.
• The second wave focuses on the integration of artificial intelligence (AI) and deep learning models for complex data analysis.
• The third wave anticipates the disruptive potential of next-generation quantum computers for life sciences and drug discovery.

Conclusions:

• Graphics processing units (GPUs) have become essential for handling large-scale life science data.
• Artificial intelligence (AI) is revolutionizing bioinformatics by enabling sophisticated pattern recognition and predictive modeling.
• Quantum computing holds significant future promise for transforming computational challenges in drug discovery and bioinformatics.